Prostate Cancer With Rising PSAPhase 1/2NCT06600698
INM176
AGN-INM176 in Prostate Patients With Rising PSA
NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial
What the film says
This trial is for men with high-risk prostate cancer that is still in or near the prostate, who are planning surgery to remove it.
The idea: treat before the operation. Lutetium-177 rhPSMA-10.1 is a radioactive medicine that attaches to PSMA, a protein on prostate cancer cells, and delivers radiation to them. Some patients also receive hormone therapy with degarelix.
Doctors measure the radiation dose that reaches the tumor, check safety, and later compare what surgeons find. At MD Anderson in Houston, Brian Chapin leads this small study, called Nautilus.
Public record; not medical advice.
Sources behind this film
High-risk prostate cancer in or near the prostate, planning surgery; Lutetium-177 rhPSMA-10.1 attaches to PSMA and delivers radiation; Some patients also receive hormone therapy with degarelix; Measure radiation dose to tumor, check safety, compare surgical findings (+1 more lines)
The drug
Participants will receive 177Lu rhPSMA-10.1 alone.
Participants will receive 177Lu rhPSMA-10.1 with Degarelix
Primary Objectives: The primary objective of the study is to assess safety and toxicity of 177Lu rhPSMA-10.1 Injection and to assess the impact of 177Lu rhPSMA-10.1 Injection with and without ADT on radiation dose delivered to the tumor in high risk localized and locoregional prostate cancer prior to primary radical prostatectomy with lymph node dissection.
The study
To learn if the proposed dose of 177Lu rhPSMA-10.1 is safe. Phase 2 will open if the Phase 1 dose is found to be safe. To learn about the safety and effects of 177Lu rhPSMA-10.1 alone and with androgen deprivation therapy (ADT) on patients with high-risk, localized prostate cancer before they have surgery to remove the disease.
Eligibility
Inclusion criteria as written on the registry, trimmed. The full list, with exclusions, is on the live record.
For you, or someone you love
A complex diagnosis brings new questions every week, in a trial and out of one. Triangle keeps your whole medical file together, reads it with you in plain language, and helps you and your family decide what to ask next.
Then $9 a month. Cancel anytime.
Requested from your hospitals and clinics through the national networks. Add scans, pathology and anything on paper.
Reports explained as they come in, with lab values you can follow before treatment, during a trial and after.
Ask about your own file, and walk in with questions for your oncologist or the trial team.
Share one profile with the family helping you, and with your doctors.
Members also get a deeper analysis of their records and any sequencing data, including clinical trials that may fit, reviewed by a licensed physician before they receive it.
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.
How these trials work: what Phase 1 actually is · common questions Not clinical evidence.